Sunday, November 27, 2022

Covaxin from Bharat Biotech has been approved for phase 2/3 trials on children aged 2 to 18.

The Central Drugs Standard Control Organization’s (CDSCO) Subject Expert Committee on COVID-19 met on Tuesday to discuss Bharat Biotech’s application to perform phase II/III clinical trials in children aged 2 to 18 years to assess the efficacy, reactogenicity, and immunogenicity of Covaxin jabs. Covaxin, a COVID-19 vaccine developed by Bharat Biotech of Hyderabad, has received clearance from an expert panel to perform phase 2/3 trials on children aged 2 to 18 years.

On Tuesday, an expert panel (Subject Expert Committee) recommended the drug maker’s anti-COVID vaccine for phase II/III clinical trials on children aged two to eighteen years, according to news agency PTI.

The trial will be conducted in 525 subjects at different locations, including AIIMS Delhi, AIIMS Patna, and Meditrina Institute of Medical Sciences in Nagpur, according to official sources.

The Central Drugs Standard Control Organization’s (CDSCO) Subject Expert Committee on COVID-19 met on Tuesday to discuss Bharat Biotech’s application to perform phase II/III clinical trials in children aged 2 to 18 years to assess the efficacy, reactogenicity, and immunogenicity of Covaxin jabs.

The idea had previously been discussed at an SEC meeting on February 24, and the company had been asked to request a revised clinical trial protocol.

ALSO CHECK: Get a tremendous discount with Firsrtcry Coupon Code and Mamaearth Coupons

Adults are being vaccinated with Covaxin, an indigenously produced vaccine by Bharat Biotech in partnership with the Indian Council of Medical Research (ICMR).

The drugmaker announced on Tuesday that it will maintain a steady supply of its COVID-19 vaccine, Covaxin, which has been sent directly to 18 states since May 1.

“Since May 1st, COVAXIN has been sent directly to 18 states. We will continue to supply our #vaccine in a steady supply, unwavering in our efforts “In a tweet, Bharat Biotech said.

Andhra Pradesh, Delhi, Bihar, Gujarat, Haryana, Uttar Pradesh, and West Bengal are among the states, according to the Hyderabad-based company.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Latest

Corona Alert: Be alert.. Another wave of corona coming? This report brought about the whole world

Covid-19New Wave: Another horrific Corona report has surfaced. According to the article, more cases will be reported worldwide in the coming months. From now...

WHO warns about new variants of Coronavirus, told how dangerous it will be

WHO warns about future variants of Covid-19: Coronavirus infection is increasing continuously in many countries around the world including India and in the meantime,...

Is this India’s fifth Monkeypox case? Patna woman suspected of infection has ALL symptoms

Patna: On Tuesday, the Bihar Health Department discovered a possible case of monkeypox in Patna's Gurhatta neighborhood. The victim is a woman, and a...

Covid-19: Corona raised concern, number of active patients in the country crossed 1.32 lakh, 45 people died

Concerns among the populace have been rekindled by the rise in the number of active corona patients in the nation. According to information provided...

Coronavirus 4th Wave: Omicron, the dangerous variant of Corona, has changed form again, know how much danger is there for India

Covid-19 Omicron Sub-Variant BA.2.75: Amidst the increasing infection of the coronavirus, the Omicron variant has once again changed its form, and a new sub-variant...

Most Popular

Subscribe

* indicates required